Reports

The audit will cover the expenditures and obligations of HAVA CARES Act and Election Security grants from date of award through September 30, 2023. The objectives are to determine if USVI 1) used funds for authorized purposes in accordance with requirements; 2) properly accounted for and controlled property purchased with HAVA payments, and 3) used the funds in a manner consistent with the informational plans provided to EAC. We will also confirm that USVI took appropriate corrective actions to address deficiencies noted in OIG's October 2013 audit report.

The audit will cover the expenditures and obligations of HAVA Requirement Payments, Election Security grants, and the CARES Act grants from the date of award through March 31, 2023. The objectives are to determine 1) if the State used funds for authorized purposed in accordance with requirements; 2) properly accounted for and controlled property purchased with HAVA payments; and (3) used the funds in a manner consistent with the informational plans provided to EAC.

The audit will cover the expenditures and obligations of HAVA Requirement Payments, Election Security grants, and the CARES Act grants from the date of award through March 31, 2023. The objectives are to determine 1) if the State used funds for authorized purposed in accordance with requirements; 2) properly accounted for and controlled property purchased with HAVA payments; and (3) used the funds in a manner consistent with the informational plans provided to EAC.

The audit will cover the expenditures and obligations of HAVA Requirement Payments, Election Security grants, and the CARES Act grants from the date of award through March 31, 2023. The objectives are to determine 1) if the State used funds for authorized purposed in accordance with requirements; 2) properly accounted for and controlled property purchased with HAVA payments; and (3) used the funds in a manner consistent with the informational plans provided to EAC.

The audit will cover the expenditures and obligations of HAVA Requirement Payments, Election Security grants, and the CARES Act grants from the date of award through March 31, 2022. The objectives are to determine 1) if the State used funds for authorized purposed in accordance with requirements; 2) properly accounted for and controlled property purchased with HAVA payments; and (3) used the funds in a manner consistent with the informational plans provided to EAC.

The preliminary objective of the audit is to determine if GSA implemented guidance from the Centers for Disease Control and Prevention and the U.S. Environmental Protection Agency, as well as followed GSA policies, to ensure the water is safe in GSA-controlled facilities after decreased occupancy from the COVID-19 pandemic.

The OIG is conducting an audit of the Office on Violence Against Women’s Grant Administration due to the COVID-19 Pandemic.  The preliminary objectives are to assess: (1) the grant administration and monitoring during the pandemic and (2) the guidance and assistance provided to grant recipients for addressing any increased risks to effective program implementation and to violence against women.

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020. 

CDC Immunization and Vaccines for Children Cooperative Agreement awardees, which are typically State and large metropolitan area public health departments, plan for and oversee the vaccine distribution and administration process. Stakeholders have acknowledged challenges early in Phase 1 distribution and dispensing, and note that these challenges will likely span all three phases identified in the CDC's COVID-19 Vaccine Playbook. We will interview all awardees to identify the reported challenges they are facing while distributing and dispensing vaccines. We will also ask awardees about effective strategies to mitigate those challenges, new challenges they anticipate, and how HHS can best support them in distributing and dispensing COVID-19 vaccines. In doing so, this review will provide HHS with timely and actionable information to address challenges associated with the COVID-19 vaccination efforts.